Group A and C meningococcal polysaccharide vaccine (Sanofi Pasteur)

A群C群脑膜炎球菌多糖疫苗（赛诺菲巴斯德）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGroup A and C meningococcal polysaccharide vaccine (Sanofi Pasteur)

Drug Alias NamePolysaccharide meningococcal A+C vaccine (Sanofi Pasteur)MENINGO A+C美宁安A+CMeningococcal A+C

ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMeningococcal Infections

Global Approved IndicationsMeningococcal Infections

Approved Indications in ChinaMeningococcal Infections

Original Approved Country/TerritoryN/A

Original Approved Date2009/06/01

Country/TerritoryHungaryGermanySpain +[5]

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaWithdrawn

Originator CompaniesSanofi Pasteur

China Registration ClassN/A

Develop Information

Active CompaniesSanofi Pasteur

Inactive CompaniesN/A

Active IndicationsMeningococcal Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A